GlaxoSmithKline logo

Corporate Responsibility Report 2008

Working with healthcare professionals

Our policies governing interactions between GSK R&D staff and healthcare practitioners require that:

  • All clinical trial investigators must be selected solely on their qualifications to conduct good quality clinical research. Their history of using or not using GSK products must not be taken into account when deciding whether to include or exclude them in a particular trial
  • Payments to practitioners are governed by contracts and any compensation reflects fair market value for the work performed
  • No payments are offered or made to influence their judgement on whether to enrol or maintain a participant in a clinical study
  • Gifts to healthcare professionals involved in research projects for GSK are not permitted.

From 2009, the PhRMA Code on Interactions with Healthcare Professionals also prohibits non-educational gifts to healthcare professionals involved in research. GSK policies have prohibited these gifts to healthcare professionals involved in research since 2006.

We are also committing to disclose research payments made to healthcare professionals and institutions. This will start with payments to US healthcare professionals and institutions for conduct of clinical trials starting in 2010. Thereafter it will be extended to payments for other types of research and to healthcare professionals and institutions outside the US.

Read more about our policies and monitoring systems that govern our relationships with healthcare professionals.